Pfizer ' s chaotic year wraps up with plunging stock, grim guidance

Investors who own Pfizer Inc. NYSE: PFE may have expected 2023 to be what football teams call a "rebuilding year." The company shifted its focus away from COVID-19 drugs and toward potential deals, share buybacks, and new treatments in its pipeline. While rebuilding years are often messy, Pfizer's…#pfizerinc #pfe #pfizer #xlv #modernainc #seagen #ubs #barclays #truist #marketbeat

Source: Reuters: Health - December 21, 2023 Category: Consumer Health News Source Type: news